Results 1 to 10 of about 53,616 (262)
Evaluation of cellular immune response and biosafety of SV40 virus-like particle in tumor immunotherapy [PDF]
Virus-like particle (VLP) holds great promise for applications in vaccines and tumor immunotherapy. However, their clinical translation has been limited by a lack of comprehensive in vivo studies on immune responses and antigenic toxicity. In this study,
Ting He +6 more
doaj +2 more sources
THE INFLUENCE OF THE PERFORATION DENSITY AND DAMAGED ZONE PERMEABILITY ON A GAS WELL PRODUCTION [PDF]
The exploitation of wellbore condensate deposits must be carried out in such a way that both water and condensate from the productive layer are not entrained during extraction.
Alexandra Catalina Damascan +2 more
doaj +1 more source
Abstract P-40: The Shape and Size of the Recombinant Virus-like Particles Were Checked by Means of Electron Microscope [PDF]
Background: Nucleocapsid protein of hepatitis-B virus (HBcAg) recombinantly synthesized in prokaryotic and eukaryotic cells is known to be capable to self-assemble into highly immunogenic stable viral-like particles (VLP) of icosahedral shape with a ...
Ivan Okhrimenko +5 more
doaj +1 more source
Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative Luciferase-Vpr packaging-based assay [PDF]
The HIV-1 auxiliary protein Vpr and Vpr-fusion proteins can be copackaged with Gag precursor (Pr55Gag) into virions or membrane-enveloped virus-like particles (VLP).
Elisabeth Errazuriz +9 more
core +15 more sources
Chimeric MrNV-GE11-VLPs serve as a nano-container to deliver Doxorubicin into cancer cells [PDF]
We have reported that virus-like particle from shrimp virus, MrNV-VLP, effectively encapsulates and delivers plasmid DNA and dsRNA into Sf9 insect cells and shrimp tissues.
Khwanthana Grataitong +4 more
doaj +1 more source
RNA Phage VLP-Based Vaccine Platforms [PDF]
Virus-like particles from a variety of RNA bacteriophages have turned out to be useful platforms for delivery of vaccine antigens in a highly immunogenic format. Here we update the current state of development of RNA phage VLPs as platforms for presentation of diverse antigens by genetic, enzymatic, and chemical display methods.
David S. Peabody +3 more
openaire +3 more sources
Production of HPV16-L1 through BL21/pET32a expression system [PDF]
Introduction: The Human papillomaviruses (HPV) main capsid protein L1 is naturally capable to self-assemble as virus-like particles (VLPs). There are different recombinant protein expression systems such as bacteria, yeast, insect, plant, and mammalian ...
Sanaz Jahandideh +3 more
doaj +1 more source
Several vaccines have been widely used to counteract the global pandemic caused by SARS-CoV-2. However, due to the rapid emergence of SARS-CoV-2 variants of concern (VOCs), further development of vaccines that confer broad and longer-lasting protection ...
Mai Komori +17 more
doaj +1 more source
This paper proposes a novel Non-linear Camera Assisted-Received Signal Strength (nCA-RSS) algorithm. The basic idea of nCA-RSS is to simultaneously utilize camera and Photo-Diode (PD) to capture visual information and signal strength information to ...
Song-lin JIA +3 more
doaj +1 more source
Enveloped virus-like particles as a platform for vaccine development
Vaccination is the most effective approach in preventing and controlling the global public health threat of infectious diseases. Enveloped virus-like particles (eVLPs) offer advantages over other subunit vaccines because of their self-adjuvanting ...
Francisco Diaz-Mitoma
doaj +1 more source

